Keywords: wyeth, reports, strong, ph, ii, data, tsecs

Wyeth reports strong Ph II data on TSECs

Article | 06 November 2006

Print This

US drug major Wyeth presented strong Phase II clinical data on the use of a bazedoxifene/conjugated estrogens complex in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in